General Information of Drug (ID: DMMSFEU)

Drug Name
2-(1-adamantyl) pyrrolidine Drug Info
Synonyms
2-(1-adamantyl)pyrrolidine; 2-(adamantan-1-yl)pyrrolidine; 180258-96-2; 2-Adamantan-1-yl-pyrrolidine; 2-(tricyclo[3.3.1.1~3,7~]dec-1-yl)pyrrolidine; AC1LADDP; SCHEMBL587943; CHEMBL323901; CTK5J7450; YVRRAISBZUMEJB-UHFFFAOYSA-N; MolPort-004-320-513; ALBB-007403; ZX-AN006941; BBL022461; STK504519; AKOS016345558; AKOS000157977; RTR-059731; MCULE-4533332464; ACM180258962; TR-059731; W-9623; Pyrrolidine, 2-tricyclo[3.3.1.1~3,7~]dec-1-yl-, (2S)-
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
511811
TTD Drug ID
DMMSFEU

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Amantadine DMS3YE9 Influenza A virus infection 1E30 Approved [2]
Rimantadine DM5DWMU Influenza A virus infection 1E30 Approved [3]
TCN-032 DM9PVNJ Influenza virus infection 1E30-1E32 Phase 2 [4]
B-Octylglucoside DMMO75G Discovery agent N.A. Investigative [5]
Spiro[piperidine-2,2-adamantane] DMWU9PV Discovery agent N.A. Investigative [1]
2-(1-adamantyl) piperidine DM05OJD Discovery agent N.A. Investigative [1]
Rimantadine isomer 2 DM3BEF7 Discovery agent N.A. Investigative [1]
3-(2-adamantyl) pyrrolidine DMS98WA Discovery agent N.A. Investigative [1]
Spiro[pyrrolidine-2,2-adamantane] DMW48JD Discovery agent N.A. Investigative [1]
2-(1-adamantyl)-2-methyl-pyrrolidine DMIGRMV Discovery agent N.A. Investigative [1]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Influenza M2 protein (Influ M) TTXT3PU M2_I34A1 Inhibitor [1]

References

1 Antiviral agents active against influenza A viruses. Nat Rev Drug Discov. 2006 Dec;5(12):1015-25.
2 Discovery of spiro-piperidine inhibitors and their modulation of the dynamics of the M2 proton channel from influenza A virus. J Am Chem Soc. 2009 Jun 17;131(23):8066-76.
3 Antiviral resistance of influenza A (H3N2) strains isolated in northern Greece between 2004 and 2007. Euro Surveill. 2009 Jan 29;14(4). pii: 19104.
4 Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci U S A. 2010 July 13; 107(28): 12658-12663.
5 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.